15 completed. 15 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 15 | Completed 15 |
| Phase 2 | 4 | Completed 4 |
Follow Transdermal Patch: new trials by email Literature Review of Transdermal Patch trials Research Report on Transdermal Patch
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1 of 3) Combination Nicotine Replacement Therapy (patch and lozenge) - Remote vs. In-Person, Remote Visits | Phase 2 / Phase 3 | Completed | State University of New York at Buffalo | 200 | 2025-03-10 | 2026-10-21 |
| Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients Nicotine 7 mg/ 24h Transdermal Patch - 24 Hour, Placebo of NICOTINE Transdermal patch - SARS-COV2 | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 32 | 2020-12-09 | 2022-02-11 |
| Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients Patch, Nicotine, Patch, Placebo - Covid19, SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 220 | 2020-11-06 | 2021-06-22 |
| Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia. Low Dose Asenapine maleate transdermal patch, High Dose Asenapine maleate transdermal patch, Placebo - Schizophrenia | Phase 3 | Completed | Noven Pharmaceuticals, Inc. | 617 | 2016-08-01 | 2020-10-22 |
| Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma Transdermal Patch, Loxoprofen sodium, Placebo (for loxoprofen sodium) - Trauma, Pain | Phase 3 | Completed | Daiichi Sankyo Brasil Farmacêutica LTDA | 242 | 2015-10-01 | 2017-02-14 |
| Web-based Smoking Cessation Program for Tribal College Students Internet-All Nations Breath of Life (I-ANBL), Honoring the Gift of Heart Health, Nicotine gum, Patch, or Lozenge or Zyban® or Chantix® - Smoking Cessation | Phase 3 | Completed | Won Choi, PhD, MPH | 251 | 2015-05-01 | 2021-12-07 |
| Efficacy of MySkin Patch for the Healing of Cut Injuries and Abrasions MySkin patch, Gauze and Patch - Wounds and Injuries, Abrasion | Phase 3 | Completed | Associazione Infermieristica per lo studio delle Lesioni Cutanee | 180 | 2012-04-01 | 2014-01-13 |
| Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System AG200-15 (cycles 1-13), Lessina crossover to AG200-15 - Contraception | Phase 3 | Completed | Agile Therapeutics | 1504 | 2010-08-01 | 2018-07-03 |
| Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy Skin biopsy, Lidocaine 5% patches - Diabetic Peripheral Neuropathy | Phase 2 / Phase 3 | Completed | Albany Medical College | 51 | 2009-10-01 | 2020-06-11 |
| HKT-500 in the Treatment of Adult Patients With Ankle Sprain Ketoprofen Patch, Placebo Patch - Ankle Sprain | Phase 3 | Completed | Hisamitsu Pharmaceutical Co., Inc. | 240 | 2009-07-01 | 2015-06-04 |
| Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia rivastigmine, placebo - Parkinson's Disease, Apathy | Phase 3 | Completed | University Hospital, Lille | 40 | 2009-03-01 | 2012-04-24 |
| A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain Fentanyl 1-day transdermal patch (Titration Phase), Fentanyl 1-day transdermal patch (Double Blind Phase), Fentanyl 3-day transdermal patch (Double Blind Phase) - Pain, Cancer | Phase 2 / Phase 3 | Completed | Janssen Pharmaceutical K.K. | 156 | 2007-12-01 | 2013-06-13 |
| Non-Nicotine Agents for Smoking Cessation bupropion and transdermal patch, transdermal patch and nicotine inhaler - Tobacco Use Disorder | Phase 3 | Completed | US Department of Veterans Affairs | 2003-10-01 | 2008-04-04 | |
| Testosterone Replacement Therapy in Chronic Spinal Cord Injury Testosterone Transdermal System (Androderm 5 mg patch) - Spinal Cord Injury, Hypogonadism | Phase 2 / Phase 3 | Completed | VA Office of Research and Development | 31 | 2003-08-01 | 2017-11-01 |
| Amblyopia (Lazy Eye) Treatment Study Atropine, Patch - Amblyopia, Anisometropia | Phase 3 | Completed | National Eye Institute (NEI) | 20 | 1999-05-01 | 2008-03-04 |
COVID-19 (2) · Pain (2) · Smoking Cessation (2) · Wounds and Injuries (2) · Amblyopia (1) · Anisometropia (1) · Ankle Injuries (1) · Hypogonadism (1) · Lethargy (1) · Neoplasms (1) · Parkinson Disease (1) · Schizophrenia (1) · Smoking (1) · Spinal Cord Injuries (1) · Strabismus (1)
Assistance Publique - Hôpitaux de Paris (2) · Agile Therapeutics (1) · Albany Medical College (1) · Associazione Infermieristica per lo studio delle Lesioni Cutanee (1) · Daiichi Sankyo Brasil Farmacêutica LTDA (1) · Hisamitsu Pharmaceutical Co., Inc. (1) · Janssen Pharmaceutical K.K. (1) · National Eye Institute (NEI) (1) · Noven Pharmaceuticals, Inc. (1) · State University of New York at Buffalo (1) · US Department of Veterans Affairs (1) · University Hospital, Lille (1) · VA Office of Research and Development (1) · Won Choi, PhD, MPH (1)
United States (9) · France (3) · Brazil (1) · Italy (1) · Japan (1)
David Devos, MD, PhD (1) · Elizabeth Garner, MD, MPH (1) · George Harb, MD, MPH (1) · Tommaso Bianchi (1) · William Bauman, MD (1) · Won Choi, PhD, MPH (1)
PMID 10319217, PMID 10376632, PMID 10623981, PMID 15851777, PMID 17349504, PMID 21252493, PMID 21717386, PMID 2205779, PMID 23343764, PMID 24218528, PMID 24402597, PMID 24968251, PMID 25582984, PMID 25586864, PMID 33326711, PMID 3344884, PMID 3461421, PMID 35676335, PMID 35687858, PMID 3674268, PMID 7609956
2008 (1), R01CA174481 (1), UH3TR004797 (1)